← Back to Search

Neurophysiological Analysis for Understanding Volition in Normal Physiology

N/A

Waitlist Available

Led By Lauren B Reoma, M.D.

Research Sponsored by National Institute of Neurological Disorders and Stroke (NINDS)

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age between 25-45 years

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up throughout

Awards & highlights

Study Summary

This trial is studying free will. Researchers want to assess the role of consciousness when intentions are present with behavior. Healthy adults ages 25-45 may be eligible. The study involves 1 visit lasting up to 4 hours.

Who is the study for?

This study is for healthy, right-handed adults aged 25-45 who speak English fluently and can follow the study's procedures. It's not for those who drink heavily, have had serious brain injuries or conditions, suffer from major depression or psychiatric illnesses, or have used illegal drugs recently.Check my eligibility

What is being tested?

Researchers are studying 'free will' by analyzing participants' brain activity and muscle movements as they make decisions. They'll use EEG to record brain waves and EMG to monitor muscle activity while subjects perform tasks like moving their wrist in response to visual cues.See study design

What are the potential side effects?

The side effects of this trial are minimal since it involves non-invasive techniques like EEG and TMS. Participants might experience discomfort from electrode caps or gel on the scalp during EEG recording, but these methods are generally well tolerated.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 25 and 45 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ throughout

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~throughout

This trial's timeline: 3 weeks for screening, Varies for treatment, and throughout for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Experiment 1: Identification of the EEG characteristic or ERP shape related to different stimuli and the brain region origin.

Experiment 2: Reaction time and accuracies of the responses to different stimuli (symbols, faces, objects, etc.) in different conditions (with and without masking)

Experiment1: Identification of the best characteristics that allow us to create a backward masking effect of the second stimulus on the first one.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Healthy VolunteersExperimental Treatment2 Interventions

Healthy Volunteers

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

EMG

2020

N/A

~1530

EEG

2013

N/A

~3530

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institute of Neurological Disorders and Stroke (NINDS)Lead Sponsor

1,341 Previous Clinical Trials

649,350 Total Patients Enrolled

12 Trials studying Normal Physiology

1,717 Patients Enrolled for Normal Physiology

Lauren B Reoma, M.D.Principal InvestigatorNational Institute of Neurological Disorders and Stroke (NINDS)

2 Previous Clinical Trials

1,286 Total Patients Enrolled

Sara K Inati, M.D.Principal InvestigatorNational Institute of Neurological Disorders and Stroke (NINDS)

5 Previous Clinical Trials

2,837 Total Patients Enrolled

Media Library

EEG Clinical Trial Eligibility Overview. Trial Name: NCT04344470 — N/A

Normal Physiology Research Study Groups: Healthy Volunteers

Normal Physiology Clinical Trial 2023: EEG Highlights & Side Effects. Trial Name: NCT04344470 — N/A

EEG 2023 Treatment Timeline for Medical Study. Trial Name: NCT04344470 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I meet the requirements to partake in this medical investigation?

"For inclusion in this clinical trial, applicants must be of age 25 to 45 and have normal physiological characteristics. To fill the study requirements, 50 participants need to sign up for the initiative."

Answered by AI

How many subjects are participating in this experiment?

"Affirmative. Clinicaltrials.gov has reported that this research endeavour, initially published on December 22nd 2020 , is currently recruiting participants. The trial requires 50 individuals to be recruited from a single site."

Answered by AI

Are participants still being sought out for this scientific endeavor?

"Affirmative. The data accessible on clinicaltrials.gov reveals that the medical trial, which was first posted on December 22nd 2020, is currently recruiting patients. A total of 50 individuals must be enrolled from 1 distinct location."

Answered by AI

Does this research program admit people below the age of twenty?

"This clinical trial stipulates that the cohort must be aged between 25 and 45. There are alternative trials available for those young than eighteen years old as well as senior citizens over 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Study of Volition: Behavioral Analysis and Clinical Neurophysiological Analysis

2020. "Study of Volition: Behavioral Analysis and Clinical Neurophysiological Analysis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04344470.